Form 8-K · Current report
General Dynamics 8-K, filed Jul 29, 2026
- Filed
- CIK
- 0000040533
- Accession no.
- 0000040533-26-000029
Summary
General Dynamics reported second-quarter 2026 revenue of $14.1 billion, up 8.1% year over year, diluted earnings per share of $4.24, up 13.4%, and a 1.4-to-1 book-to-bill ratio on $20 billion of orders, with backlog of $136.5 billion. Chairman and CEO Phebe Novakovic said revenue grew across all four segments and that the company is investing to increase output to meet demand.
Key points
- Revenue was $14.1 billion, up 8.1% from the year-ago quarter, with growth in all four segments; Aerospace rose 15.1% and Marine Systems 10.4%.
- Diluted EPS was $4.24, up 13.4%, and operating margin was 10.4%, a 40-basis-point expansion.
- Orders totaled $20 billion in the quarter, a 1.4-to-1 company-wide book-to-bill ratio, and backlog ended at $136.5 billion.
- The company paid $429 million in dividends, invested $234 million in capital expenditures, and reduced total debt by $498 million, ending with $7.5 billion total debt and $4.3 billion cash.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition On July 29, 2026, General Dynamics announced its financial results for the quarter ended July 5, 2026. A copy of the press release is being furnished as Exhibit 99.1 to this Form 8-K and is hereby incorporated by reference. Item 9.01 Financial Statements and Exhibits (d) Exhibits (furnished only) 99.1 General Dynamics press release dated July 29, 2026, with respect to the company’s financial results for the quarter ended July 5, 2026. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.